IP Library Granted Patent US 11,622,971
Granted Patent B2
US 11,622,971 · App. 16/951,009 · Granted Apr 11, 2023

Tryptamine compositions for enhancing neurite outgrowth

Inventor: Paul Edward Stamets (Shelton, WA)
Assignee: TURTLE BEAR HOLDINGS, LLC
A61K31/661A61K31/05A61K31/352A61K31/455A61K36/066A61K36/07A61K36/73A61P25/24
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,622,971
App. No.
16/951,009
Granted
Apr 11, 2023
Kind
B2
Abstract

Described herein are neurotrophic and nootropic compositions and methods for treating subjects with such compositions. In one aspect the composition comprises one or more tryptamines or in pure form or extracts from psilocybin containing mushrooms, or combinations thereof optionally combined with one or more phenethylamines or amphetamines in pure form or extracts from a plant or mushroom, or combinations thereof, optionally one or more erinacines or hericenones in pure form, extracts from Hericium mushroom species (e.g., H. erinaceus, H. coralloides, H. ramosum ) or combinations thereof, optionally one or more cannabinoids in pure form or extracts from Cannabis sativa, Cannabis sativa, Cannabis indica , or Cannabis ruderalis , optionally, one or more adversive compounds, and optionally one or more pharmaceutically acceptable excipients.

Claims (7)

1. A pharmaceutical composition comprising:

0.5-4 mg of norpsilocin or a salt or combinations thereof; and

0.5-4 mg of niacin.

2. The composition of claim 1 , wherein the composition further comprises an extract of or isolate from Hericium erinaceus.

3. The composition of claim 1 , wherein the composition further comprises one or more cannabinoids in pure form or extracts or isolates from Cannabis sativa, Cannabis sativa, Cannabis indica , or Cannabis ruderalis.

4. The composition of claim 1 , wherein the composition comprises one or more pharmaceutically acceptable excipients.

5. The composition of claim 1 , wherein the composition is a powder admixture, liquid, suspension, or emulsion.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 7, 2021
From: STAMETS, PAUL E.
To: TURTLE BEAR HOLDINGS, LLC
Reel/Frame 055960/0665 →
Continuity (3)
Provisional Application 62937536 · Nov 19, 2019
Provisional Application 63007482 · Apr 9, 2020
Related Publication 20210145851A1 · May 20, 2021